Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added the RELIVE trial publication reference to the Publications section, including the Lancet Gastroenterol Hepatol 2019 paper and its erratum/update notes. The prior entry for this publication was revised accordingly.
    Difference
    0.1%
    Check dated 2026-02-05T15:20:00.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the revision to v3.4.0; several metadata labels were reformatted (e.g., capitalization changes in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data') and older labels were removed.
    Difference
    0.1%
    Check dated 2026-01-29T07:29:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added in the page header; a minor update that does not affect core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:47:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Publications section briefly added then removed the RELIVE Lancet Gastroenterol Hepatol article citation; this back-and-forth does not affect core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-08T01:33:55.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added study locations in Ohio and Pennsylvania and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the previous Ohio and Pennsylvania location entries.
    Difference
    0.2%
    Check dated 2025-12-24T14:28:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Publications are described as auto-filled from PubMed, and the page revision was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:02.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.